Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Prevention of Weight Regain After GLP1RA Cessation With Oral TIX100.
Journal: Diabetes, obesity & metabolism
Published: January 07, 2026
Target Discovery to Diabetes Therapy-TXNIP From Bench to Bedside With NIDDK.
Journal: Endocrinology
Published: January 03, 2025
Oral TIX100 protects against obesity-associated glucose intolerance and diet-induced adiposity.
Journal: Diabetes, obesity & metabolism
Published: November 03, 2024
A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging.
Journal: Frontiers in endocrinology
Published: August 05, 2024
Proinsulin regulators identified with CRISPR screen and in vivo mouse QTL mapping.
Journal: Nature communications
Published: May 28, 2024
Data-driven Cluster Analysis Reveals Increased Risk for Severe Insulin-deficient Diabetes in Black/African Americans.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 16, 2024
An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges.
Journal: Journal of clinical and translational science
Published: July 10, 2023
What the BTBR/J mouse has taught us about diabetes and diabetic complications.
Journal: iScience
Published: June 26, 2023
LDB1-mediated transcriptional complexes are sensitive to islet stress.
Journal: Islets
Published: December 30, 2021
Last Updated: 09/26/2026